tirzepatide alopecia GLP-1 therapies and hair loss: A systematic review of current evidence and implications for counseling What are we doing about

The results of the SUSTAIN 7 trial comparing the efficacy of Novo Nordisks semaglutide with Eli Lillys Trulicity (dulaglutide), already in the market, have revealed that Novos drug seems to be better at helping patients with type 2 diabetes control their blood sugar levels and reduce weight

Choose the time that fits your routine best so you're more likely to stay adherent

Review other medications: Check for possible sedating effects or absorption issues caused by slower digestion

Available from: Yong W, Shibo W, Jingang L

CMS Issued Clarifying Guidance on Medicare GLP-1 Coverage for Cardiovascular Indications Following semaglutide's SELECT trial resultswhich demonstrated cardiovascular risk reduction in non-diabetic patients with obesitythe Centers for Medicare & Medicaid Services (CMS) issued updated guidance

Patients with hypertension should receive appropriate first-line antihypertensive therapy according to NICE hypertension guidelines (NG136), which recommend ACE inhibitors, angiotensin receptor blockers, calcium channel blockers, or thiazide-like diuretics as initial treatment depending on age, ethnicity, and comorbidities